Abstract
Migraine is a complex disorder with many different manifestations. There has been an increasing interest in the association of migraine and vertigo. Many different terms have been developed to describe this concept, the more popular being vestibular migraine, migrainous vertigo, and migraine-associated vertigo. The most commonly cited diagnostic criteria are that of Neuhauser though this has yet to be included in the International Classification of Headache Disorders (2nd edition). At this time, there is a lack of consensus regarding migraine-related vertigo and its pathomechanism. Regardless, a few randomized controlled prospective studies have been performed to evaluate the efficacy of various medications. Topiramate has been shown to be effective for migraine-related vertigo. At this time there is no specific treatment for migraine-related dizziness outside of conventional migraine management. The genetics have yet to be fully realized though an autosomal dominant familial migraine vertigo disorder has been identified.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalagia. 2004;24 Suppl 1:1–160.
Bisdorff A, Von Brevern M, Lempert T, et al. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19:1–13.
Lempert T, Neuhauser H. Epidemiology of vertigo, migraine, and vestibular migraine. J Neurol. 2009;256:333–8.
Hsu LC, Wang SJ, Fuh JL. Prevalence and impact of migrainous vertigo in mid-life women. a community-based study. Cephalalgia. 2011;31:77–83.
Dix MR, Hallpike CS. Pathology, symptoms, and diagnosis of certain disorders of the vestibular system. Proc R Soc Med. 1952;45:341–54.
American Academy of Otolaryngology-Head and Neck Foundation, Inc. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg. 1995;113:181–5.
•• Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56:436–41. This paper is of historical significance as it was an early paper discussing the overlap of migraine and vertigo and it also provided an approach to its classification.
Strupp M, Versino M, Brandt T. Vestibular migraine. Handb Clin Neurol. 2010;97:755–71.
• Eggers SD, Staab JP, Neff BA, et al. Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol. 2011;32:1144–51. This is a recent article that discusses migraine and vertigo and identifies some of the pitfalls in the diagnosis of vestibular migraine. The results of the retrospective review do not allow for a meaningful separation between “definite” and “probable” vestibular migraine.
Ferber-Viart C, Dubreuil C, Duclaux R. Vestibular evoked myogenic potentials in humans. A review. Acta Otolaryngol. 1999;119:6–15.
Hong SM, Kim SK, Park CH, et al. Vestibular-evoked myogenic potentials in migrainous vertigo. Otolaryngol Head Neck Surg. 2011;144:284–7.
Szirmai A. Vestibular disorders in patients with migraine. Eur Arch Otorhinolaryngol. 1997;254:S55–7.
Bahmad Jr F, DePalma SR, Merchant SN, et al. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Oto Rhino Laryngol. 2009;118:670–6.
Oh AK, Lee H, Jen JC, et al. Familial benign recurrent vertigo. Am J Med Genet. 2001;15:287–91.
Gode S, Celebisoy N, Kirazli T, Akyuz A, Bilgen C, Karapolat H, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84.
Neuhauser H, Radtke A, von Brevern M, et al. Zolmitriptan for treatment of migrainous vertigo. A pilot randomized placebo-controlled trial. Neurology. 2003;60:882–3.
Gottshall KR, Moore RJ, Hoffer ME. Vestibular rehabilitation for migraine-associated dizziness. Int Tinnitus J. 2005;11:81–4.
Whitney SL, Wrisley DM, Brown KE, et al. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope. 2000;110:1528–34.
Young WB, Peres MF, Rozen TD. Modular theory of migraine. Cephalalgia. 2001;21:842–9.
Tepper SJ, Tepper DE. Breaking the cycle of medication overuse headache. Cleve Clin J Med. 2010;77:236–42.
Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway; perspective and implications to migraine pathophysiology. J Clin Neurol. 2012;8:89–99.
Murdin L, Davies RA, Bronstein AM. Vertigo as a migraine trigger. Neurology. 2009;25:638–42.
de Jong PT, de Jong JM, Cohen B, Jongkees LB. Ataxia and nystagmus induced by injection of local anesthetics in the Neck. Ann Neurol. 1977;1:240–6.
Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes—prolonged effects from a single injection. Pain. 2006;122:126–9.
Crevits L, Bosman T. Migraine-related vertigo towards a distinctive entity. Clin Neurol Neurosurg. 2005;107:82–7.
Baron EP, Cherian N, Tepper SJ. Role of greater occipital nerve blocks and trigger point injections for patients with dizziness and headache. Neurologist. 2011;17:312–7.
Volcy M, Sheftell FD, Tepper SJ, et al. Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning? Headache. 2005;45:1083–7.
Precht W, Shimazu H, Markham CH. A mechanism of central compensation of vestibular function following hemilabyrinthectomy. J Neurophysiol. 1966;29:996–1010.
Rudge R, Chambers BR. Physiological basis for enduring vestibular symptoms. J Neurol Neurosurg Psychiatry. 1982;45:126–30.
Viirre ES, Baloh RW. Migraine as a cause of sudden hearing loss. Headache. 1996;36:24–8.
Lee H, Lopez I, Ishiyama A, et al. Can migraine damage the inner ear? Arch Neurol. 2000;57:1631–4.
Stach B. Speech audiometry and other behavioral measures. In: Stach B, editor. Clinical audiology. An introduction. San Diego: Singular Publishing; 1998. p. 241–3.
Cherian N. Improvement in hearing following occipital nerve injection. Association for Research in Otolaryngology. Poster presentation. Winter, 2008.
Kavcic V, Vaughn W, Duffy CJ. Distinct visual motion processing impairments in aging and Alzheimer’s disease. Vision Res. 2011;51:386–95.
Wray SH, Mijovic-Prelec D, Kosslyn SM. Visual processing in migraineurs. Brain. 1995;118:25–35.
Cherian N, Kriegler J. Systems engineering approach to migraine and dizziness. American Headache Society meeting. Poster presentation. June, 2007.
Disclosure
Neil Cherian declares no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Headache
Rights and permissions
About this article
Cite this article
Cherian, N. Vertigo as a Migraine Phenomenon. Curr Neurol Neurosci Rep 13, 343 (2013). https://doi.org/10.1007/s11910-013-0343-6
Published:
DOI: https://doi.org/10.1007/s11910-013-0343-6